Select your Market
-
{{ userContent.title }}
{{ userContent.lookingForMoreLabel }}
Our Healthcare business aims to change lives
With a holistic approach, we design and develop medicines and intelligent devices that provide ongoing care for patients beyond their treatment. This includes new medications to treat rare tumors and conditions like cancer or multiple sclerosis (MS), but also innovative technologies that make life easier for patients. For example, our injection device and disease monitoring software allow patients with MS to self-inject their medicine and monitor its administration. With cancer, our precise approach uses biomarkers that can match potential treatment to individual patients. In rare tumors, we are showing up for patients in the moments that matter, beyond the clinic with integrated digital solutions with every feature genuinely built by patients for patients.
Our goal is to support people at every stage of life – also when it comes to helping create new life. We have helped many women and couples achieve their dream of having a baby. As the global market leader in fertility treatments, we do what we do with passion – and we think further ahead. We have complemented our portfolio by fertility technologies, aiming to further increase the possibility of in vitro fertilization (IVF) success.
Our purpose. Our patients.
We are united As One for Patients to help create, improve and prolong lives.
This is our purpose – the reason why we do what we do every day. Working As One for Patients motivates us to always give our best and continuously improve our efforts.
Because we understand that every single one of us, every decision and contribution we make in our work has an impact on the lives of patients and their caregivers.
We are united As One for Patients.
As One for Patients
Our therapeutic areas
Rare Tumors
With an expanding portfolio, our Rare Tumors therapeutic area centers on patients whose lives are profoundly affected by chronic symptoms, pain, frequent procedures, and uncertain future.
Explore More
Oncology
We are inspired by curiosity, science and, most importantly, patients, combining a creative approach with our relentless drive to transform the way cancer is treated.
Explore More
Neurology & Immunology
Merck has more than 20 years of experience in Multiple Sclerosis (MS) care, and remains committed to finding solutions for patients’ significant unmet medical needs.
Explore More
Fertility
With our broad portfolio of treatment options, devices and advanced fertility technologies, we aim to contribute to improved treatment outcomes that help couples fulfill the dream of parenthood.
Explore More
Endocrinology
Endocrine disorders such as growth hormone deficiency require long-term treatment. The treatments have a major effect on the patients’ wellbeing and can make a difference to their quality of life.
Explore More
General Medicine
Combining our expertise in General Medicine, our purpose is to bring better health to our patients, helping them live their life to its full potential.
Explore More
Vibrant Thoughts Blog
Science and technology are transforming how we understand disease. Discover the people behind this innovation, and the vibrant thinking that drives them to make a difference for patients.
Explore More
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study ...
Phase 3 study is evaluating Precem-TcT for the treatment of metastatic colorectal cancer (mCRC).
2026/05/21
-
Press Releases
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial ...
Merck KGaA, Darmstadt, Germany announced today that the U.S. FDA has accepted the company’s NDA for pimicotinib.
2026/01/12
-
Press Releases
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant ...
The China National Medical Products Administration (NMPA) has approved pimicotinib for adult patients with symptomatic tenosynovial giant cell tumor.
2025/12/22
Humans of Healthcare
The people who make our mission of developing innovative ways to treat and care for patients a reality come from many different backgrounds all over the world.
Meet them here
WE ARE PATIENT-DIRECTED
We have moved to a patient-directed approach, working with patients and family carers to systematically incorporate their perspectives throughout Merck’s processes to shape the way we design and deliver healthcare.
learn more
Merck Export GmbH
a healthcare company of Merck, dedicated to clinical trial supply (CTS).
learn morePosition statements
Disclaimer
This publication is intended to provide information to an international audience. Not all products discussed on this page may be available in your country and local prescribing information and approved indications may differ from country to country. For local prescribing information and approved indications, please visit our local websites.